PTC Therapeutics director sells $149,036 in shares

Markets Investing.com By Investing.com 17 Oct 2026 01:01 1 min read
PTC Therapeutics director sells $149,036 in shares

Covered in this story

Analyst targets on PTC Inc.

Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.

Call it yourself

No member calls on $PTC yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.

Make the first call on PTC Inc. →
Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.